Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Journal of Atrial Fibrillation|July 11, 2018
Biomarkers of Myocardial Injury and Inflammation after Permanent Pacemaker Implantation: The Lead Fixation Type EffectDimitrios Varvarousis, Nikolaos Goulas, Kali Polytarchou, et al.
Plos One|July 19, 2017
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancerIppokratis Messaritakis, Eleni Politaki, Athanasios Kotsakis, et al.
Oncology|July 25, 2007
A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancerMichail Ignatiadis, Aris Polyzos, George P Stathopoulos, et al.
Cells|August 11, 2023
Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip TechnologyVasileios Vardas, Julia A Ju, Athina Christopoulou, et al.
Annals of Gastroenterology|November 3, 2018
Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research GroupNikolaos Kentepozidis, Panagiota Economopoulou, Michael Liontos, et al.
Anticancer Research|April 4, 2008
Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)Antonia Kalykaki, Pavlos Papakotoulas, Sofoklis Tsousis, et al.
Journal of Geriatric Oncology|June 7, 2016
Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III studyAthanasios Karampeazis, Lambros Vamvakas, Athanasios Kotsakis, et al.
Molecular and Clinical Oncology|June 14, 2018
Small cell carcinoma of the stomach: A report of two cases and a review of the literatureMarios Bakogeorgos, Dimitrios Kalkanis, Panagiotis Katsaounis, et al.
Cancers|June 12, 2026
<i>AXL</i>-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung CancerAliki Ntzifa, Elena Themistokli, Areti Strati, et al.
Biomolecules|January 8, 2025
<i>NALCN</i> Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer PatientsEleni Thanou, Dora Lontra, Ioanna Balgouranidou, et al.
Pageof 13